JP2003192528A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JP2003192528A JP2003192528A JP2001396639A JP2001396639A JP2003192528A JP 2003192528 A JP2003192528 A JP 2003192528A JP 2001396639 A JP2001396639 A JP 2001396639A JP 2001396639 A JP2001396639 A JP 2001396639A JP 2003192528 A JP2003192528 A JP 2003192528A
- Authority
- JP
- Japan
- Prior art keywords
- component
- cosmetic
- cosmetics
- collagen
- phototoxicity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、皮膚の光老化を抑
制する作用を有する抗光老化化粧料に関する。TECHNICAL FIELD The present invention relates to an anti-photoaging cosmetic having an action of suppressing photoaging of the skin.
【0002】[0002]
【従来の技術】シワ・タルミを特徴とする皮膚の老化
は、線維芽細胞のコラーゲン産生の低下、ヒアルロン酸
合成の低下、紫外線によるコラゲナーゼ活性の増大、紫
外線や環境から生じる活性酸素による障害、さらには紫
外線による大気汚染物質の光毒性作用によるものと考え
られている。このような光に起因したシワ・タルミの改
善には、紫外線吸収剤やレチノール、レチノイン酸など
が用いられている。その他、コラーゲン、植物エキス等
の光毒性軽減作用を有するものも用いられている。BACKGROUND OF THE INVENTION Skin aging characterized by wrinkle and tarmi is caused by a decrease in collagen production by fibroblasts, a decrease in hyaluronic acid synthesis, an increase in collagenase activity by ultraviolet rays, damage by active oxygen generated by ultraviolet rays and the environment, and Is believed to be due to the phototoxic effects of ultraviolet air pollutants. An ultraviolet absorber, retinol, retinoic acid, and the like are used to improve wrinkles and tarmi caused by such light. In addition, collagen, a plant extract and the like having a phototoxicity reducing action are also used.
【0003】[0003]
【発明が解決しようとする課題】シワ・タルミの改善に
は、紫外線吸収剤やレチノール、レチノイン酸などが用
いられているが、安全性の面から副作用も強い。その
他、コラーゲン、植物エキス等に光毒性軽減作用を有す
るものが用いられているが、いずれも微弱な効果しか示
さないため、それぞれ単独で化粧料等に配合した場合、
十分な抗光老化すなわちシワ・タルミの改善効果が得ら
れなかった。Although an ultraviolet absorber, retinol, retinoic acid, etc. are used for the improvement of wrinkles and tarmi, side effects are strong from the viewpoint of safety. In addition, collagen, a plant extract, etc. having a phototoxicity reducing action are used, but since they show only a weak effect, when they are individually added to cosmetics, etc.,
A sufficient anti-aging effect, that is, an effect of improving wrinkle and tarmi was not obtained.
【0004】そこで、優れたシワ・タルミの改善効果に
ついて、副作用がなく、安全性の高い化粧料の開発が望
まれていた。[0004] Therefore, it has been desired to develop a highly safe cosmetic composition having no side effect with respect to an excellent effect of improving wrinkles and tarmi.
【0005】[0005]
【課題を解決するための手段】このような事情により、
本発明者らは皮膚の光老化改善を目的に鋭意検討した結
果、光毒性軽減作用を持つ植物エキスから選ばれる一種
または二種以上、および魚由来コラーゲンの含有物が、
優れた皮膚の光老化を抑制する作用を有することを見出
し、本発明を完成するに至った。[Means for Solving the Problems] Due to such circumstances,
As a result of intensive studies by the present inventors for the purpose of improving photoaging of the skin, one or more selected from plant extracts having a phototoxicity-reducing effect, and a fish-derived collagen-containing material,
They have found that they have an excellent effect of suppressing photoaging of the skin, and have completed the present invention.
【0006】すなわち、本発明は、下記成分(A)およ
び(B);(A)光毒性軽減作用を持つ植物エキスから
選ばれる一種または二種以上、(B)魚由来コラーゲン
を含有する皮膚の抗光老化化粧料である。That is, the present invention provides the following components (A) and (B); (A) one or more selected from plant extracts having a phototoxicity-reducing action, and (B) a skin containing fish-derived collagen. It is an anti-photoaging cosmetic.
【0007】本発明にて用いられる成分(A)の植物エ
キスとしては、光毒性軽減作用があれば特に限定されな
いが、好ましくは、フキタンポポ、エキナセア、ステビ
ア、カミツレ、トウキンセンカ、ヤグルマギク、セイヨ
ウノコギリソウ、カワラヨモギ、アルニカ、ローマンカ
ミツレ、白茶、ヤマモモ、ダイダイ、ウンシュウミカ
ン、オオベニミカン、クワ、コガネバナ、オウゴン、ト
ウキ、トウヒ、セイヨウトチノキ、ローズマリー、セー
ジ、メリッサ、アマチャ、スイカズラ等が挙げられる。The plant extract of the component (A) used in the present invention is not particularly limited as long as it has a phototoxicity-reducing action, but is preferably coltsfoot, echinacea, stevia, chamomile, pearl millet, cornflower, yarrow, Kawamura mugwort, arnica, roman chamomile, white tea, bayberry, red sea bream, citrus unshiu, Japanese red citrus, mulberry, Scutellaria baicalensis, swordfish, spruce, spruce, horse chestnut, rosemary, sage, melissa, armature, honeysuckle and the like.
【0008】抽出する溶媒としては、例えば、水、低級
アルコール類(メタノール、エタノール、1−プロパノ
ール、2−プロパノール、1−ブタノール、2−ブタノ
ール等)、液状多価アルコール(グリセリン、プロピレ
ングリコール、1,3−ブチレングリコール等)、ケト
ン類(アセトン、メチルエチルケトン等)、アセトニト
リル、エステル類(酢酸エチル、酢酸ブチル等)、炭化
水素類(ヘキサン、ヘプタン、流動パラフィン等)、エ
ーテル類(エチルエーテル、プロピルエーテル、テトラ
ヒドロフラン等)が挙げられる。好ましくは、水、低級
アルコールおよび液状多価アルコールが良く、特に好ま
しくは、水、エタノール、プロピレングリコールおよび
1,3−ブチレングリコールが良い。これらの溶媒は一
種でも二種以上を混合して用いても良い。The solvent to be extracted is, for example, water, lower alcohols (methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, etc.), liquid polyhydric alcohol (glycerin, propylene glycol, 1). , 3-butylene glycol, etc.), ketones (acetone, methyl ethyl ketone, etc.), acetonitrile, esters (ethyl acetate, butyl acetate, etc.), hydrocarbons (hexane, heptane, liquid paraffin, etc.), ethers (ethyl ether, propyl, etc.) Ether, tetrahydrofuran, etc.). Water, lower alcohols and liquid polyhydric alcohols are preferable, and water, ethanol, propylene glycol and 1,3-butylene glycol are particularly preferable. These solvents may be used alone or in combination of two or more.
【0009】これらは抽出した溶液のまま用いても良
く、必要に応じて、濃縮、希釈、濾過等の処理および活
性炭等による脱色、脱臭処理をして用いても良い。さら
には、抽出した溶液を濃縮乾固、噴霧乾燥、凍結乾燥等
の処理を行い、乾燥物として用いても良い。The extracted solutions may be used as they are, or if necessary, they may be subjected to treatments such as concentration, dilution and filtration, and decolorization and deodorization treatment with activated carbon before use. Furthermore, the extracted solution may be concentrated to dryness, spray-dried, freeze-dried and the like and used as a dried product.
【0010】本発明に用いる成分(A)の配合量は、特
に限定されていないが、好ましくは本発明における化粧
料の全量に対し、固形分に換算して0.0001重量%
以上が良く、さらに好ましくは 0.0005〜10重
量%が良い。0.0001重量%未満では十分な効果は
発揮され難い。10重量%を越えて配合した場合、効果
の増強は少なく不経済である。また、添加の方法につい
ては、予め加えておいても、製造途中で添加しても良
く、作業性を考えて適宜選択すれば良い。The amount of component (A) used in the present invention is not particularly limited, but is preferably 0.0001% by weight in terms of solid content based on the total amount of the cosmetic of the present invention.
The above is preferable, and 0.0005 to 10% by weight is more preferable. If it is less than 0.0001% by weight, it is difficult to exert a sufficient effect. When it is blended in an amount of more than 10% by weight, the effect is not enhanced so much and it is uneconomical. Regarding the method of addition, it may be added in advance or may be added during the production, and may be appropriately selected in consideration of workability.
【0011】成分(A)は、これらのうち、一種または
二種以上が本発明の化粧料に配合される。Among these, the component (A) is used alone or in combination of two or more in the cosmetic of the present invention.
【0012】本発明に用いる成分(B)である魚由来の
コラーゲンは、特に限定されないが、例えば鮭、金目
鯛、たら、ひらめ等の皮または浮袋等を洗浄、脱脂、酸
濾過、酵素処理、塩折、透析、熱処理等の手段を経て、
可溶化コラーゲン成分を抽出した後、得られるものが挙
げられる。これらは、魚由来コラーゲン溶液として市販
の化粧品に使用されている。アテロ化処理しても、加水
分解処理してもしなくても良い。The fish-derived collagen which is the component (B) used in the present invention is not particularly limited, but for example, skins such as salmon, goldfish, codfish, flounder and the like or a floating bag are washed, degreased, acid filtered, treated with an enzyme, After means such as salt folding, dialysis, and heat treatment,
The thing obtained after extracting a solubilized collagen component is mentioned. These are used in commercial cosmetics as a fish-derived collagen solution. It may or may not be atherogenic.
【0013】溶液のまま用いても良く、必要に応じて、
濃縮、希釈、濾過等の処理および活性炭等による脱色、
脱臭処理をして用いても良い。さらには、抽出した溶液
を濃縮乾固、噴霧乾燥、凍結乾燥等の処理を行い、乾燥
物として用いても良い。The solution may be used as it is, and if necessary,
Concentration, dilution, filtration, etc. and decolorization with activated carbon, etc.
It may be used after being deodorized. Furthermore, the extracted solution may be concentrated to dryness, spray-dried, freeze-dried and the like and used as a dried product.
【0014】本発明に用いる成分(B)の配合量は、特
に限定されないが、好ましくは本発明における化粧料の
全量に対し、固形分に換算して0.0001重量%以上
が良く、さらに好ましくは 0.00001〜10重量
%が良い。0.0001重量%未満では十分な効果は発
揮され難い。10重量%を越えて配合した場合、効果の
増強は少なく不経済である。また、添加の方法について
は、予め加えておいても、製造途中で添加しても良く、
作業性を考えて適宜選択すれば良い。The blending amount of the component (B) used in the present invention is not particularly limited, but is preferably 0.0001% by weight or more in terms of solid content based on the total amount of the cosmetic of the present invention, and more preferably. Is preferably 0.00001 to 10% by weight. If it is less than 0.0001% by weight, it is difficult to exert a sufficient effect. When it is blended in an amount of more than 10% by weight, the effect is not enhanced so much and it is uneconomical. Regarding the method of addition, it may be added in advance or may be added during the production,
It may be selected as appropriate in consideration of workability.
【0015】成分(B)は、これらのうち、一種または
二種以上が本発明の化粧料に配合される。As the component (B), one kind or two or more kinds of them are blended in the cosmetic of the present invention.
【0016】成分(A)および(B)の効果を損なわな
い範囲内で、通常の化粧品および医薬部外品に用いられ
る成分である油脂類、ロウ類、炭化水素類、脂肪酸類、
アルコール類、エステル類、界面活性剤、金属石鹸、p
H調整剤、防腐剤、香料、保湿剤、粉体、紫外線吸収
剤、増粘剤、色素、酸化防止剤、美白剤、キレート剤等
の成分を配合することもできる。Oils, waxes, hydrocarbons, fatty acids, which are components used in ordinary cosmetics and quasi drugs, within a range that does not impair the effects of the components (A) and (B).
Alcohols, esters, surfactants, metal soaps, p
Ingredients such as H-adjusting agents, preservatives, fragrances, humectants, powders, ultraviolet absorbers, thickeners, dyes, antioxidants, whitening agents and chelating agents can also be added.
【0017】本発明の化粧料は、化粧品および医薬部外
品のいずれにも用いることができ、その剤型としては、
例えば、化粧水、クリーム、乳液、ゲル剤、エアゾール
剤、エッセンス、パック、洗浄剤、浴用剤、ファンデー
ション、打粉、口紅等が挙げられる。The cosmetic of the present invention can be used in both cosmetics and quasi-drugs.
Examples thereof include lotions, creams, emulsions, gels, aerosols, essences, packs, detergents, bath agents, foundations, dusters, lipsticks and the like.
【0018】[0018]
【発明の効果】本発明の化粧料は、優れたシワ・タルミ
の改善効果により皮膚の光老化を抑制する作用をもたら
すものである。EFFECT OF THE INVENTION The cosmetic composition of the present invention brings about an effect of suppressing photoaging of the skin due to an excellent effect of improving wrinkles and tarmi.
【0019】[0019]
【実施例】次に本発明を詳細に説明するため、実施例と
して本発明に用いる抽出物の製造例、本発明の処方例お
よび実験例を挙げるが、本発明はこれに限定されるもの
ではない。実施例に示す配合量の部とは重量部を、%と
は重量%を示す。EXAMPLES In order to explain the present invention in detail, examples of production of extracts used in the present invention, prescription examples of the present invention and experimental examples will be given below, but the present invention is not limited thereto. Absent. The parts of the compounding amounts shown in the examples are parts by weight, and% is% by weight.
【0020】製造例1 フキタンポポの熱水抽出物
フキタンポポの乾燥物40gに400mLの精製水を加
え、95〜100℃にて2時間抽出した後、濾過し、そ
の濾液を濃縮し、凍結乾燥して熱水抽出物を1.2g得
た。Production Example 1 Hot water extract of coltsfoot, 400 ml of purified water was added to 40 g of dried coltsfoot, and the mixture was extracted at 95 to 100 ° C. for 2 hours, filtered, and the filtrate was concentrated and freeze-dried. 1.2 g of hot water extract was obtained.
【0021】製造例2 エキナセアのエタノール抽出物
エキナセアの乾燥物100gに900mLのエタノール
を加え、常温にて7日間抽出した後、濾過し、その濾液
を濃縮乾固して、エタノール抽出物を1.5g得た。Production Example 2 Ethanol extract of Echinacea 900 mL of ethanol was added to 100 g of dried Echinacea, and the mixture was extracted at room temperature for 7 days, filtered, and the filtrate was concentrated to dryness to give 1. 5 g was obtained.
【0022】製造例3 ステビアの1,3−ブチレング
リコール水溶液抽出物
ステビアの乾燥物200gに1kgの精製水および1k
gの1,3−ブチレングリコールを加え、常温にて7日
間抽出した後、濾過し、1,3−ブチレングリコール水
溶液抽出物を1.9g得た。Preparation Example 3 Stevia 1,3-butylene glycol aqueous solution extract Stevia dried product 200 g 1 kg purified water and 1 k
1,3-butylene glycol (g) was added, and the mixture was extracted at room temperature for 7 days and then filtered to obtain 1.9 g of 1,3-butylene glycol aqueous solution extract.
【0023】製造例4 酸可溶性アテロ化コラーゲン溶
液
鮭の皮を洗浄処理、脱脂、酸処理、膜濾過、塩析、透析
を経て酸可溶性コラーゲン溶液を得る。例えば、「酸可
溶性アテロ化コラーゲン溶液」(井原水産製:乾燥残分
1%)が挙げられる。Production Example 4 Acid-Soluble Atelolated Collagen Solution Salmon skin is washed, defatted, acid-treated, membrane-filtered, salted-out and dialyzed to obtain an acid-soluble collagen solution. For example, an “acid-soluble atelocollagen collagen solution” (Ihara Suisan: dry residue 1%) can be mentioned.
【0024】製造例5 水溶性コラーゲン溶液
金目鯛の皮を洗浄処理、脱脂、酸処理、膜濾過、酵素処
理、塩析、等電点沈殿、透析を経て酸可溶性コラーゲン
溶液を得る。例えば、「水溶性コラーゲン溶液」(テク
ノーブル製:乾燥残分1%)が挙げられる。Production Example 5 Water-Soluble Collagen Solution An acid-soluble collagen solution is obtained through washing treatment, degreasing, acid treatment, membrane filtration, enzyme treatment, salting out, isoelectric focusing and dialysis. For example, "water-soluble collagen solution" (manufactured by Technoble: dry residue 1%) can be mentioned.
【0025】製造例6 牛由来アテロ化コラーゲン溶液
牛皮を洗浄処理、脱脂、酸処理、膜濾過、酵素処理、塩
析、等電点沈殿、透析を経て酸可溶性コラーゲン溶液を
得る。例えば、乾燥残分1%の水溶液が挙げられる。Production Example 6 Cattle-derived atelolated collagen solution Cowhide is washed, defatted, acid-treated, membrane-filtered, enzyme-treated, salted-out, isoelectrically precipitated and dialyzed to obtain an acid-soluble collagen solution. For example, an aqueous solution having a dry residue of 1% can be used.
【0026】
実施例1 クリーム1
処方 配合量
1.フキタンポポの熱水抽出物(製造例1) 0.05部
2.酸可溶性アテロ化コラーゲン溶液(製造例4) 0.1
3.スクワラン 5.5
4.オリーブ油 3.0
5.ステアリン酸 2.0
6.ミツロウ 2.0
7.ミリスチン酸オクチルドデシル 3.5
8.ポリオキシエチレンセチルエーテル(20E.O.) 3.0
9.ベヘニルアルコール 1.5
10.モノステアリン酸グリセリン 2.5
11.香料 0.1
12.1,3−ブチレングリコール 8.5
13.パラオキシ安息香酸エチル 0.05
14.パラオキシ安息香酸メチル 0.2
15.精製水にて全量を100とする
[製造方法]成分3〜10を加熱溶解して混合し、70
℃に保ち油相とする。成分1、2および12〜15を加
熱溶解して混合し、75℃に保ち水相とする。油相に水
相を加えて乳化して、かき混ぜながら冷却し、45℃に
て成分11を加え、更に30℃まで冷却して製品とす
る。Example 1 Cream 1 formulation Compounding amount 1. Hot water extract of coltsfoot (Production Example 1) 0.05 parts 2. Acid-soluble atelo-collagen solution (Production Example 4) 0.1 3. Squalane 5.5 4. Olive oil 3.0 5. Stearic acid 2.0 6. Beeswax 2.0 7. Octyldodecyl myristate 3.5 8. Polyoxyethylene cetyl ether (20 EO) 3.0 9. Behenyl alcohol 1.5 10. Glycerin monostearate 2.5 11. Fragrance 0.1 12.1, 3-butylene glycol 8.5 13. Ethyl paraoxybenzoate 0.05 14. Methyl paraoxybenzoate 0.2 15. [Manufacturing method] The total amount is 100 with purified water. Components 3 to 10 are dissolved by heating and mixed, and 70
Keep at ℃ and use as oil phase. Ingredients 1, 2 and 12 to 15 are dissolved by heating and mixed, and the mixture is kept at 75 ° C to form an aqueous phase. The aqueous phase is added to the oil phase to emulsify, the mixture is cooled with stirring, component 11 is added at 45 ° C, and further cooled to 30 ° C to obtain a product.
【0027】比較例1 従来のクリーム1
実施例1において、成分1および2を精製水に置き換え
たものを従来のクリーム1とした。Comparative Example 1 Conventional Cream 1 A conventional cream 1 was prepared by replacing components 1 and 2 with purified water in Example 1.
【0028】比較例2 従来のクリーム2
実施例1において、成分1の熱水抽出物を精製水に置き
換えたものを従来のクリーム2とした。Comparative Example 2 Conventional Cream 2 A conventional cream 2 was prepared by replacing the hot water extract of the component 1 in Example 1 with purified water.
【0029】比較例3 従来のクリーム3
実施例1において、成分2を精製水に置き換えたものを
従来のクリーム3とした。Comparative Example 3 Conventional Cream 3 In Example 1, the conventional cream 3 was prepared by replacing the component 2 with purified water.
【0030】
実施例2 化粧水
処方 配合量
1.エキナセアのエタノール抽出物(製造例2) 0.1部
2.酸可溶性アテロ化コラーゲン溶液(製造例4) 0.01
3.1,3−ブチレングリコール 8.0
4.グリセリン 2.0
5.キサンタンガム 0.02
6.クエン酸 0.01
7.クエン酸ナトリウム 0.1
8.エタノール 5.0
9.パラオキシ安息香酸メチル 0.1
10.ポリオキシエチレン硬化ヒマシ油(40E.O.) 0.1
11.香料 0.1
12.精製水にて全量を100とする
[製造方法]成分1〜7および12と、成分8〜11を
それぞれ均一に溶解し、両者を混合し濾過して製品とす
る。Example 2 Cosmetic lotion formulation Amount 1. 1. Echinacea ethanol extract (Production Example 2) 0.1 part 2. Acid-soluble atelocollagen collagen solution (Production Example 4) 0.01 3.1,3-butylene glycol 8.0 4. Glycerin 2.0 5. Xanthan gum 0.02 6. Citric acid 0.01 7. Sodium citrate 0.1 8. Ethanol 5.0 9. Methyl paraoxybenzoate 0.1 10. Polyoxyethylene hydrogenated castor oil (40 EO) 0.1 11. Perfume 0.1 12. [Manufacturing method] The total amount is 100 with purified water Components 1 to 7 and 12 and components 8 to 11 are uniformly dissolved, and both are mixed and filtered to obtain a product.
【0031】
実施例3 乳液
処方 配合量
1.エキナセアのエタノール抽出物(製造例2) 0.5部
2.酸可溶性アテロ化コラーゲン溶液(製造例4) 5.0
3.スクワラン 5.0
4.オリーブ油 5.0
5.ホホバ油 5.0
6.セタノール 1.5
7.モノステアリン酸グリセリン 2.0
8.ポリオキシエチレンセチルエーテル(20E.O.) 3.0
9.ポリオキシエチレンソルビタンモノオレエート(20E.O.)2.0
10.香料 0.1
11.プロピレングリコール 1.0
12.グリセリン 2.0
13.パラオキシ安息香酸メチル 0.2
14.精製水にて全量を100とする
[製造方法]成分3〜9を加熱溶解して混合し、70℃
に保ち油相とする。成分1、2および11〜14を加熱
溶解して混合し、75℃に保ち水相とする。油相に水相
を加えて乳化して、かき混ぜながら冷却し、45℃にて
成分10を加え、更に30℃まで冷却して製品とする。Example 3 Emulsion formulation Compounding amount 1. Echinacea ethanol extract (Production Example 2) 0.5 part 2. Acid soluble atelocollagen collagen solution (Production Example 4) 5.0 3. Squalane 5.0 4. Olive oil 5.0 5. Jojoba oil 5.0 6. Cetanol 1.5 7. Glycerin monostearate 2.0 8. Polyoxyethylene cetyl ether (20 EO) 3.0 9. Polyoxyethylene sorbitan monooleate (20 EO) 2.0 10. Perfume 0.1 11. Propylene glycol 1.0 12. Glycerin 2.0 13. Methyl paraoxybenzoate 0.2 14. [Manufacturing method] The total amount is 100 with purified water. Components 3 to 9 are dissolved by heating and mixed, and the mixture is heated to 70 ° C.
Keep it in the oil phase. Ingredients 1, 2 and 11 to 14 are dissolved by heating and mixed, and the mixture is kept at 75 ° C to form an aqueous phase. The water phase is added to the oil phase to emulsify, and the mixture is cooled with stirring, component 10 is added at 45 ° C, and further cooled to 30 ° C to obtain a product.
【0032】
実施例4 ゲル剤
処方 配合量
1.フキタンポポの熱水抽出物(製造例1) 0.1部
2.酸可溶性アテロ化コラーゲン溶液(製造例4) 1.0
3.エタノール 5.0
4.パラオキシ安息香酸メチル 0.1
5.ポリオキシエチレン硬化ヒマシ油(60E.O.) 0.1
6.香料 0.1
7.1,3−ブチレングリコール 5.0
8.グリセリン 5.0
9.キサンタンガム 0.1
10.カルボキシビニルポリマー 0.2
11.水酸化カリウム 0.2
12.精製水にて全量を100とする
[製造方法]成分1〜6と、成分7〜12をそれぞれ均
一に溶解し、両者を混合して製品とする。Example 4 Gel formulation Formulation amount 1. Hot water extract of coltsfoot (Production Example 1) 0.1 part 2. Acid-soluble atelocollagen collagen solution (Production Example 4) 1.0 3. Ethanol 5.0 4. Methyl paraoxybenzoate 0.1 5. Polyoxyethylene hydrogenated castor oil (60 EO) 0.1 6. Fragrance 0.1 7.1, 1,3-butylene glycol 5.0 8. Glycerin 5.0 9. Xanthan gum 0.1 10. Carboxyvinyl polymer 0.2 11. Potassium hydroxide 0.2 12. [Production method] Components 1 to 6 and components 7 to 12 each having a total amount of 100 with purified water are uniformly dissolved, and both are mixed to obtain a product.
【0033】 実施例5 パック 処方 配合量 1.ステビアの1,3−ブチレングリコール水溶液抽出物(製造例3)0.2部 2.水溶性コラーゲン溶液(製造例5) 10.0 3.ポリビニルアルコール 12.0 4.エタノール 5.0 5.1,3−ブチレングリコール 8.0 6.パラオキシ安息香酸メチル 0.2 7.ポリオキシエチレン硬化ヒマシ油(20E.O.) 0.5 8.クエン酸 0.1 9.クエン酸ナトリウム 0.3 10.香料 0.1 11.精製水にて全量を100とする [製造方法]成分1〜11を均一に溶解し製品とする。[0033] Example 5 Pack Prescription amount 1. 0.2 parts of 1,3-butylene glycol aqueous solution extract of stevia (Production Example 3) 2. Water-soluble collagen solution (Production Example 5) 10.0 3. Polyvinyl alcohol 12.0 4. Ethanol 5.0 5.1,3-butylene glycol 8.0 6. Methyl paraoxybenzoate 0.2 7. Polyoxyethylene hydrogenated castor oil (20EO) 0.5 8. Citric acid 0.1 9. Sodium citrate 0.3 10. Perfume 0.1 11. Adjust the total volume to 100 with purified water [Production method] Components 1 to 11 are uniformly dissolved to obtain a product.
【0034】
実施例6 ファンデーション
処方 配合量
1.ステビアの1,3−ブチレングリコール水溶液抽出物(製造例3)1.0部
2.酸可溶性アテロ化コラーゲン溶液(製造例4) 0.05
3.ステアリン酸 2.4
4.ポリオキシエチレンソルビタンモノステアレート(20E.O.)1.0
5.ポリオキシエチレンセチルエーテル(20E.O.) 2.0
6.セタノール 1.0
7.液状ラノリン 2.0
8.流動パラフィン 3.0
9.ミリスチン酸イソプロピル 6.5
10.パラオキシ安息香酸ブチル 0.1
11.カルボキシメチルセルロースナトリウム 0.1
12.ベントナイト 0.5
13.プロピレングリコール 4.0
14.トリエタノールアミン 1.1
15.パラオキシ安息香酸メチル 0.2
16.二酸化チタン 8.0
17.タルク 4.0
18.ベンガラ 1.0
19.黄酸化鉄 2.0
20.香料 0.1
21.精製水にて全量を100とする
[製造方法]成分3〜10を加熱溶解し、80℃に保ち
油相とする。成分21に成分11をよく膨潤させ、続い
て、成分1、2および12〜15を加えて均一に混合す
る。これに粉砕機にて粉砕混合した成分16〜19を加
え、ホモミキサーにて撹拌し、75℃に保ち水相とす
る。この水相に油相をかき混ぜながら加え、冷却し、4
5℃にて成分20を加え、かき混ぜながら30℃まで冷
却して製品とする。Example 6 Foundation Formulation Amount 1. 1.0 part of 1,3-butylene glycol aqueous solution extract of stevia (Production Example 3) 1. Acid-soluble atelocollagen solution (Production Example 4) 0.05 3. Stearic acid 2.4 4. Polyoxyethylene sorbitan monostearate (20EO) 1.0 5. Polyoxyethylene cetyl ether (20 EO) 2.0 6. Cetanol 1.0 7. Liquid lanolin 2.0 8. Liquid paraffin 3.0 9. Isopropyl myristate 6.5 10. Butyl paraoxybenzoate 0.1 11. Carboxymethyl cellulose sodium 0.1 12. Bentonite 0.5 13. Propylene glycol 4.0 14. Triethanolamine 1.1 15. Methyl paraoxybenzoate 0.2 16. Titanium dioxide 8.0 17. Talc 4.0 18. Bengal 1.0 19. Yellow iron oxide 2.0 20. Perfume 0.1 21. [Production method] Components 3 to 10 are heated and dissolved in purified water to a total amount of 100 and kept at 80 ° C to form an oil phase. Ingredient 21 is swelled well into ingredient 21, and subsequently ingredients 1, 2 and 12 to 15 are added and mixed uniformly. Components 16 to 19 pulverized and mixed with a pulverizer are added to this, and the mixture is stirred with a homomixer and kept at 75 ° C to form an aqueous phase. Add the oil phase to this water phase while stirring and cool.
Add component 20 at 5 ° C and cool to 30 ° C with stirring to obtain a product.
【0035】
実施例7 浴用剤
処方 配合量
1.ステビアの1,3−ブチレングリコール水溶液抽出物(製造例3)1.0部
2.水溶性コラーゲン溶液(製造例5) 0.1
3.炭酸水素ナトリウム 50.0
4.黄色202号(1) 0.1
5.香料 0.1
6.無水硫酸ナトリウムにて全量を100とする
[製造方法]成分1〜6を均一に混合し製品とする。な
お、成分1および2は凍結乾燥品を用いる。Example 7 Formulation of bath agent Blending amount 1. 1.0 part of 1,3-butylene glycol aqueous solution extract of stevia (Production Example 3) Water-soluble collagen solution (Production Example 5) 0.1 3. Sodium hydrogen carbonate 50.0 4. Yellow No. 202 (1) 0.1 5. Fragrance 0.1 6. [Manufacturing method] The total amount is 100 with anhydrous sodium sulfate. Components 1 to 6 are uniformly mixed to obtain a product. As components 1 and 2, freeze-dried products are used.
【0036】次に、本発明の効果を詳細に説明するた
め、実験例を挙げる。Next, in order to explain the effects of the present invention in detail, experimental examples will be given.
【0037】実験例−1 魚由来コラーゲンの有効配合
量
紫外線照射後の皮膚弾力低下に対する魚由来コラーゲン
の有効配合量を検討した。実験は6週齢雄性マウスの背
部に紫外線A波を照射し、比較例1のクリームにおい
て、フキタンポポ熱水抽出物の有無、またはコラーゲン
の配合量をいくつか変えて塗布した。照射と塗布を30
日間連続で行い、試験終了後に皮膚弾力を測定した。Experimental Example-1 Effective amount of collagen derived from fish The effective amount of collagen derived from fish against reduction in skin elasticity after ultraviolet irradiation was examined. In the experiment, the back of 6-week-old male mice was irradiated with ultraviolet A waves, and the cream of Comparative Example 1 was applied with or without the hot water extract of coltsfoot, or with some amounts of collagen mixed. Irradiation and application 30
The test was conducted continuously for a day, and the skin elasticity was measured after the test was completed.
【0038】結果を表1に示した。対照は紫外線未照射
のマウス皮膚弾力を示す。皮膚弾力の低下に対するフキ
タンポポ熱水抽出物の添加により有効であった。魚由来
コラーゲンの改善効果はその配合量に依存し、0.00
01%以上で優れた効果を示した。ただし、10%を超
えて配合しても効果の増強は認められなかった。The results are shown in Table 1. The control shows the elasticity of mouse skin not irradiated with ultraviolet rays. It was effective by adding coltsfoot hot water extract to reduce skin elasticity. The improvement effect of fish-derived collagen depends on its amount,
An excellent effect was shown at 01% or more. However, no enhancement of the effect was observed even if the content was more than 10%.
【0039】[0039]
【表1】 魚由来コラーゲンの有効配合量 [Table 1] Effective amount of collagen derived from fish
【0040】実験例−2 光毒性軽減作用
Balb/c 3T3細胞を用い、代表的な大気汚染物
質であるベンツピレンを添加した培地に、フキタンポポ
熱水抽出物(製造例1)、酸可溶性アテロ化コラーゲン
溶液(製造例4)および両方の物質を添加した場合、ま
た、フキタンポポ熱水抽出物と製造例−6の牛由来アテ
ロ化コラーゲン溶液の両方を添加した場合における細胞
生存率を測定した。Experimental Example 2 Phototoxicity-reducing action Balb / c 3T3 cells were used, and a medium containing benzpyrene, which is a typical air pollutant, was added to a hot water extract of coltsfoot dandelion (Production Example 1) and acid-soluble atelocollagen. The cell viability was measured when the solution (Production Example 4) and both substances were added, and when both the hot water coltsfoot extract and the bovine-derived atelocollagen collagen solution of Production Example-6 were added.
【0041】その結果、表2に示すように、細胞生存率
はフキタンポポ熱水抽出物による処理では60%、酸可
溶性アテロ化コラーゲン溶液による処理では20%、こ
れらを同時に処理することにより70%の生存率を示
し、フキタンポポ抽出物による光毒性軽減作用を認め
た。しかし、牛由来アテロ化コラーゲン溶液によるフキ
タンポポ熱水抽出物の効果の増強は見られなかった。As a result, as shown in Table 2, the cell viability was 60% by the treatment with the hot water extract of coltsfoot, 20% by the treatment with the acid-soluble atelocollagen collagen solution, and 70% by the simultaneous treatment thereof. The survival rate was shown, and the phototoxicity reducing effect of the coltsfoot extract was confirmed. However, the effect of the hot water coltsfoot extract was not observed by the bovine-derived atelocollagen solution.
【0042】[0042]
【表2】光毒性軽減作用 [Table 2] Phototoxicity reduction effect
【0043】実験例−3 シワ・タルミにおける改善効
果
実施例−1のクリーム、比較例−1〜3の従来のクリー
ムを用いて、肌のタルミおよび小ジワに悩む女性20人
(25〜40才)を対象に1ヶ月間の使用試験を行っ
た。使用後、肌のタルミ、小ジワの改善効果を自己申告
により評価した。Experimental Example-3 Improvement effect on wrinkle / talmi Using the cream of Example-1 and the conventional creams of Comparative Examples-1 to 3, 20 women (25 to 40 years old) suffering from skin wrinkles and fine wrinkles. ) Was used for a one-month use test. After use, the effect of improving skin tarmi and fine wrinkles was evaluated by self-report.
【0044】その結果、表3および4に示すように、フ
キタンポポおよび鮭由来酸可溶性アテロ化コラーゲン溶
液を含有することを特徴とする化粧料は優れた改善効果
を示した。As a result, as shown in Tables 3 and 4, cosmetics characterized by containing coltsfoot and salmon-derived acid-soluble atelo-collagen collagen solution showed excellent improving effects.
【0045】[0045]
【表3】 肌のタルミに対する改善効果 [Table 3] Improvement effect on skin tarmi
【0046】[0046]
【表4】 小ジワに対する改善効果 [Table 4] Improvement effect for small wrinkles
【0047】実施例2〜7で得られた化粧料はいずれも
十分なシワ・タルミにおける改善効果を示すものであっ
た。The cosmetics obtained in Examples 2 to 7 all showed a sufficient effect of improving wrinkles and tarmi.
【0048】[0048]
【発明の効果】以上のことから、本発明の本発明は下記
成分(A)および(B);
(A)光毒性軽減作用を持つ植物エキスから選ばれる一
種または二種以上、(B)魚由来コラーゲンを含有する
ことを特徴とする抗光老化化粧料は安定性に優れ、肌に
対して優れた作用を示した。From the above, the present invention of the present invention comprises the following components (A) and (B); (A) one or more selected from plant extracts having a phototoxicity-reducing action, and (B) fish. The anti-photoaging cosmetics, which are characterized by containing the collagen derived therefrom, were excellent in stability and showed an excellent effect on the skin.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 赤座 誠文 名古屋市西区鳥見町2−7 日本メナード 化粧品株式会社総合研究所内 (72)発明者 小島 肇夫 名古屋市西区鳥見町2−7 日本メナード 化粧品株式会社総合研究所内 (72)発明者 堅田 友則 名古屋市西区鳥見町2−7 日本メナード 化粧品株式会社総合研究所内 Fターム(参考) 4C083 AA082 AA111 AA112 AA122 AB032 AB232 AB242 AB312 AB352 AB432 AB442 AC022 AC072 AC102 AC122 AC182 AC242 AC302 AC352 AC422 AC432 AC482 AC542 AC842 AD092 AD112 AD272 AD352 AD431 AD432 AD512 CC02 CC04 CC05 CC07 CC12 CC25 DD31 DD41 EE12 EE13 EE17 ─────────────────────────────────────────────────── ─── Continued front page (72) Inventor Seika Akaza 2-7 Torimicho, Nishi-ku, Nagoya-shi Japan Menard Cosmetics Research Institute (72) Inventor Hajime Kojima 2-7 Torimicho, Nishi-ku, Nagoya-shi Japan Menard Cosmetics Research Institute (72) Inventor Tomonori Katata 2-7 Torimicho, Nishi-ku, Nagoya-shi Japan Menard Cosmetics Research Institute F-term (reference) 4C083 AA082 AA111 AA112 AA122 AB032 AB232 AB242 AB312 AB352 AB432 AB442 AC022 AC072 AC102 AC122 AC182 AC242 AC302 AC352 AC422 AC432 AC482 AC542 AC842 AD092 AD112 AD272 AD352 AD431 AD432 AD512 CC02 CC04 CC05 CC07 CC12 CC25 DD31 DD41 EE12 EE13 EE17
Claims (7)
種または二種以上、(B)魚由来コラーゲンを含有する
ことを特徴とする化粧料1. A makeup comprising the following components (A) and (B); (A) one or more selected from plant extracts having a phototoxicity-reducing action, and (B) fish-derived collagen. Fee
である請求項1の化粧料2. A cosmetic according to claim 1, which is an anti-photoaging cosmetic containing the component according to claim 1.
の化粧料3. The method according to claim 1, which has a phototoxicity reducing action.
Cosmetics
5〜10重量%、成分(B)の量0.00001〜10
重量%の請求項1または3の化粧料4. The amount of component (A) is 0.000 as solid content.
5-10% by weight, amount of component (B) 0.00001-10
% Of cosmetics according to claim 1 or 3.
ステビア、カミツレ、トウキンセンカ、ヤグルマギク、
セイヨウノコギリソウ、カワラヨモギ、アルニカ、ロー
マンカミツレ、白茶、ヤマモモ、ダイダイ、ウンシュウ
ミカン、オオベニミカン、クワ、コガネバナ、オウゴ
ン、トウキ、トウヒ、セイヨウトチノキ、ローズマリ
ー、セージ、メリッサ、アマチャ、スイカズラから1種
または2種以上選ばれる請求項1〜4の化粧料5. Component (A) is coltsfoot, echinacea,
Stevia, chamomile, quince, cornflower,
Achillea millefolium, sagebrush, arnica, roman chamomile, white tea, bayberry, red sea bream, citrus unshiu, mandarin orange, mulberry, chafer, sorghum, spruce, spruce, horse chestnut, rosemary, sage, melissa, spruce seeds, watermelon The cosmetics according to claims 1 to 4 selected above
ステビアから選ばれる請求項1〜5の化粧料6. The component (A) comprises coltsfoot, echinacea,
Cosmetics according to claims 1 to 5 selected from stevia
溶液または水溶性コラーゲン溶液である請求項1〜6の
化粧料7. The cosmetic composition according to claim 1, wherein the component (B) is an acid-soluble atelocollagen collagen solution or a water-soluble collagen solution.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001396639A JP2003192528A (en) | 2001-12-27 | 2001-12-27 | Cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001396639A JP2003192528A (en) | 2001-12-27 | 2001-12-27 | Cosmetic |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2003192528A true JP2003192528A (en) | 2003-07-09 |
Family
ID=27602679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001396639A Pending JP2003192528A (en) | 2001-12-27 | 2001-12-27 | Cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2003192528A (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003192566A (en) * | 2001-12-27 | 2003-07-09 | Nonogawa Shoji Kk | Cosmetic |
JP2006117552A (en) * | 2004-10-19 | 2006-05-11 | Hayashibara Biochem Lab Inc | Skin care preparation for photo-aging prevention |
JP2008503505A (en) * | 2004-06-25 | 2008-02-07 | フェロサン・アクティーゼルスカブ | Composition suitable for treating skin signs of aging |
JP2008074784A (en) * | 2006-09-22 | 2008-04-03 | Mandom Corp | Skin care emulsified composition |
JP2011088845A (en) * | 2009-10-21 | 2011-05-06 | Kao Corp | Involucrin expression inhibitor |
JPWO2009123215A1 (en) * | 2008-03-31 | 2011-07-28 | 株式会社 資生堂 | Oral, injection, external skin preparation and cosmetic method for preventing or improving wrinkles |
JP2012224872A (en) * | 2012-08-23 | 2012-11-15 | Kobayashi Pharmaceutical Co Ltd | Stabilizing agent for composition that contains water-soluble polymeric thickener |
CN103784365A (en) * | 2014-01-08 | 2014-05-14 | 片仔癀(上海)生物科技研发有限公司 | Whitening cream and preparation method thereof |
FR3002447A1 (en) * | 2013-02-28 | 2014-08-29 | Oreal | Composition, useful e.g. to stimulate, restore or regulate the metabolism of melanocyte in the skin, comprises rebaudioside A and a polymer with polyvinyl alcohol repeating unit and optionally vinyl acetate repeating unit |
FR3002446A1 (en) * | 2013-02-28 | 2014-08-29 | Oreal | Cosmetic composition, useful for stimulating, restoring or regulating the metabolism of melanocyte in the skin, skin cells or semi-mucous membranes, comprises rebaudioside A and at least one cellulose substitute in a medium |
JP2015086183A (en) * | 2013-10-31 | 2015-05-07 | ポーラ化成工業株式会社 | Composition for skin photoaging prevention |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09278639A (en) * | 1996-04-05 | 1997-10-28 | Taiken Enterp:Kk | Cosmetic containing collagen |
JPH1143425A (en) * | 1997-07-28 | 1999-02-16 | Nippon Bio Kk | External preparation for skin |
JP2000119155A (en) * | 1998-10-14 | 2000-04-25 | Kose Corp | Skin lotion |
JP2000229832A (en) * | 1999-02-09 | 2000-08-22 | Shiseido Co Ltd | Skin lotion |
JP2001151633A (en) * | 1999-11-26 | 2001-06-05 | Noevir Co Ltd | Preparation for external use for skin |
WO2001066076A2 (en) * | 2000-03-06 | 2001-09-13 | Unilever Plc | Echinacea extract as anti-irritant and anti-aging booster in cosmetic compositions |
JP2001354539A (en) * | 2000-06-08 | 2001-12-25 | Noevir Co Ltd | Skin care preparation |
JP2002226356A (en) * | 2001-02-06 | 2002-08-14 | Ichimaru Pharcos Co Ltd | Collagen-containing cosmetic composition derived from pigment-free fish skin |
JP2003171224A (en) * | 2001-12-11 | 2003-06-17 | Nonogawa Shoji Kk | Cosmetic |
JP2003176219A (en) * | 2001-12-13 | 2003-06-24 | Ichimaru Pharcos Co Ltd | Collagen tripeptide-containing skin care preparation |
JP2003183122A (en) * | 2001-12-21 | 2003-07-03 | Ichimaru Pharcos Co Ltd | Agent for inhibiting activity of collagenase |
JP2003183171A (en) * | 2001-12-21 | 2003-07-03 | Ichimaru Pharcos Co Ltd | Elastase activity inhibitor |
JP2003192566A (en) * | 2001-12-27 | 2003-07-09 | Nonogawa Shoji Kk | Cosmetic |
-
2001
- 2001-12-27 JP JP2001396639A patent/JP2003192528A/en active Pending
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09278639A (en) * | 1996-04-05 | 1997-10-28 | Taiken Enterp:Kk | Cosmetic containing collagen |
JPH1143425A (en) * | 1997-07-28 | 1999-02-16 | Nippon Bio Kk | External preparation for skin |
JP2000119155A (en) * | 1998-10-14 | 2000-04-25 | Kose Corp | Skin lotion |
JP2000229832A (en) * | 1999-02-09 | 2000-08-22 | Shiseido Co Ltd | Skin lotion |
JP2001151633A (en) * | 1999-11-26 | 2001-06-05 | Noevir Co Ltd | Preparation for external use for skin |
WO2001066076A2 (en) * | 2000-03-06 | 2001-09-13 | Unilever Plc | Echinacea extract as anti-irritant and anti-aging booster in cosmetic compositions |
JP2001354539A (en) * | 2000-06-08 | 2001-12-25 | Noevir Co Ltd | Skin care preparation |
JP2002226356A (en) * | 2001-02-06 | 2002-08-14 | Ichimaru Pharcos Co Ltd | Collagen-containing cosmetic composition derived from pigment-free fish skin |
JP2003171224A (en) * | 2001-12-11 | 2003-06-17 | Nonogawa Shoji Kk | Cosmetic |
JP2003176219A (en) * | 2001-12-13 | 2003-06-24 | Ichimaru Pharcos Co Ltd | Collagen tripeptide-containing skin care preparation |
JP2003183122A (en) * | 2001-12-21 | 2003-07-03 | Ichimaru Pharcos Co Ltd | Agent for inhibiting activity of collagenase |
JP2003183171A (en) * | 2001-12-21 | 2003-07-03 | Ichimaru Pharcos Co Ltd | Elastase activity inhibitor |
JP2003192566A (en) * | 2001-12-27 | 2003-07-09 | Nonogawa Shoji Kk | Cosmetic |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003192566A (en) * | 2001-12-27 | 2003-07-09 | Nonogawa Shoji Kk | Cosmetic |
JP2008503505A (en) * | 2004-06-25 | 2008-02-07 | フェロサン・アクティーゼルスカブ | Composition suitable for treating skin signs of aging |
US11039999B2 (en) | 2004-06-25 | 2021-06-22 | Ferrosan Aps | Compositions suitable for treating cutaneous signs of aging |
JP2006117552A (en) * | 2004-10-19 | 2006-05-11 | Hayashibara Biochem Lab Inc | Skin care preparation for photo-aging prevention |
JP2008074784A (en) * | 2006-09-22 | 2008-04-03 | Mandom Corp | Skin care emulsified composition |
JP2014208720A (en) * | 2008-03-31 | 2014-11-06 | 株式会社 資生堂 | Preparation for preventing or ameliorating wrinkles, to be taken orally, through injection, or through external application to skin, and cosmetic method |
JPWO2009123215A1 (en) * | 2008-03-31 | 2011-07-28 | 株式会社 資生堂 | Oral, injection, external skin preparation and cosmetic method for preventing or improving wrinkles |
JP5722030B2 (en) * | 2008-03-31 | 2015-05-20 | 株式会社 資生堂 | Oral, injection, external skin preparation and cosmetic method for preventing or improving wrinkles |
JP2011088845A (en) * | 2009-10-21 | 2011-05-06 | Kao Corp | Involucrin expression inhibitor |
JP2012224872A (en) * | 2012-08-23 | 2012-11-15 | Kobayashi Pharmaceutical Co Ltd | Stabilizing agent for composition that contains water-soluble polymeric thickener |
FR3002446A1 (en) * | 2013-02-28 | 2014-08-29 | Oreal | Cosmetic composition, useful for stimulating, restoring or regulating the metabolism of melanocyte in the skin, skin cells or semi-mucous membranes, comprises rebaudioside A and at least one cellulose substitute in a medium |
FR3002447A1 (en) * | 2013-02-28 | 2014-08-29 | Oreal | Composition, useful e.g. to stimulate, restore or regulate the metabolism of melanocyte in the skin, comprises rebaudioside A and a polymer with polyvinyl alcohol repeating unit and optionally vinyl acetate repeating unit |
JP2015086183A (en) * | 2013-10-31 | 2015-05-07 | ポーラ化成工業株式会社 | Composition for skin photoaging prevention |
CN103784365A (en) * | 2014-01-08 | 2014-05-14 | 片仔癀(上海)生物科技研发有限公司 | Whitening cream and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2003300858A (en) | Skin care preparation | |
JP2003192566A (en) | Cosmetic | |
JP2003192528A (en) | Cosmetic | |
JPH08325130A (en) | Cosmetic | |
JPH0859450A (en) | External preparation for skin | |
JP2003192567A (en) | Cosmetic | |
JP2004231558A (en) | External preparation for skin for bleaching | |
JP2004161641A (en) | Cosmetic | |
JP4824181B2 (en) | Topical skin preparation | |
JP2003192526A (en) | Cosmetic | |
JP4628604B2 (en) | Skin preparation | |
JP2003192565A (en) | Cosmetic | |
JP2002154919A (en) | Elongation inhibitor of dendrite of melanocyte and cosmetic comprising the same | |
JPH05194175A (en) | Cosmetic | |
JP2000159653A (en) | Preparation for external use for skin | |
JP2003171226A (en) | Skin care preparation | |
JP2009234976A (en) | Cell activator and external preparation for skin for antiaging | |
JP2002154920A (en) | Elongation inhibitor of dendrite of melanocyte and cosmetic comprising the same | |
JP3044690B2 (en) | Cosmetics | |
JP6468595B2 (en) | Topical skin preparation | |
JPH0696511B2 (en) | Cosmetics | |
JPH09175980A (en) | Cosmetic | |
JP4485154B2 (en) | Skin external preparation for wrinkle prevention improvement | |
JP5415216B2 (en) | Topical skin preparation | |
JP5468866B2 (en) | Topical skin preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20041117 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20041203 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20050520 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050531 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050714 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20051011 |